The ECTRIMS Podcast
The European Committee for Treatment and Research in Multiple Sclerosis
The world is better when its people are connected. The ECTRIMS Podcast aims to be a sounding board for MS experts & advocates to discuss innovative work in MS research, treatment and care with the greater MS research community, while offering a collaborative platform for MS and healthcare experts to promote & nurture the advancement of research.
Categories: Science & Medicine
Add to My List
Listen to the last episode:
Fatigue is a common symptom of multiple sclerosis, significantly impacting the quality of life of people living with the disease. In this episode, Dr. Anne-Laure Dubessy of Hôpital Pitié-Salpêtrière in Paris and Professor Iris-Katharina Penner of the University Hospital of Bern in Switzerland join host Brett Drummond of MSTranslate to discuss the causes of MS-related fatigue, strategies for managing it, and the latest research developments in this area.
Previous episodes
-
51 - Fatigue in Multiple SclerosisThu, 16 Jan 2025 - 0h
-
50 - Addressing Diversity in MS Research and CareThu, 12 Dec 2024 - 0h
-
49 - Paediatric Multiple SclerosisWed, 27 Nov 2024 - 0h
-
48 - MS Prodrome: Implications and Future Research DirectionsThu, 07 Nov 2024 - 0h
-
47 - Episode 37: Future MS TherapeuticsThu, 24 Oct 2024 - 0h
-
46 - MS Nurses at ECTRIMS 2024Thu, 10 Oct 2024 - 0h
-
45 - Patient Community Day Highlights of ECTRIMS 2024: Part IIWed, 09 Oct 2024 - 0h
-
44 - Patient Community Day Highlights of ECTRIMS 2024: Part IThu, 03 Oct 2024 - 0h
-
43 - Advancing MS Knowledge through the ECTRIMS FellowshipMon, 23 Dec 2024 - 0h
-
42 - Day 3 Highlights of ECTRIMS 2024Fri, 20 Sep 2024 - 0h
-
41 - Day 2 Highlights of ECTRIMS 2024Thu, 19 Sep 2024 - 0h
-
40 - Day 1 Highlights of ECTRIMS 2024Wed, 18 Sep 2024 - 0h
-
39 - Pre-Day Highlights of ECTRIMS 2024Tue, 17 Sep 2024 - 0h
-
38 - Episode 35: NMOSD and MOGAD Part IITue, 10 Sep 2024 - 0h
-
37 - Episode 35: NMOSD and MOGAD Part ITue, 10 Sep 2024 - 0h
-
36 - ECTRIMS-EAN Vaccination Consensus Statement (eanCast)Wed, 04 Sep 2024 - 0h
-
35 - Environmental, Genetic, and Epigenetic Risk Factors in MSThu, 15 Aug 2024 - 0h
-
34 - Myelin plasticity and repairTue, 23 Jul 2024 - 0h
-
33 - Lifestyle Modifications in MSTue, 25 Jun 2024 - 0h
-
32 - The Impact of Ageing on MSWed, 05 Jun 2024 - 0h
-
31 - Artificial Intelligence in MS ResearchThu, 16 May 2024 - 0h
-
30 - Prioritising Women's Health Topics in MS ResearchSat, 20 Apr 2024 - 0h
-
29 - Spotlight on Young MS ResearchersFri, 29 Mar 2024 - 0h
-
28 - MS in the Black CommunityThu, 07 Mar 2024 - 0h
-
27 - Efforts Towards a Better MS Diagnostic CriteriaTue, 13 Feb 2024 - 0h
-
26 - Factoring in Female Health in the MS JourneyWed, 31 Jan 2024 - 0h
-
25 - The Importance of Patient Community DayThu, 11 Jan 2024 - 0h
-
24 - Genetics and MS SeverityFri, 15 Dec 2023 - 0h
-
23 - Defining MS Subtypes in Clinical PracticeThu, 30 Nov 2023 - 0h
-
22 - The Changing Role of MS NursesWed, 15 Nov 2023 - 0h
-
21 - Discontinuing DMTs in Patients with Stable Relapsing-remitting MS: When and How?Fri, 10 Nov 2023 - 0h
-
20 - Day Three Highlights of MSMilan2023Fri, 13 Oct 2023 - 0h
-
19 - Day Two Highlights of MSMilan2023Thu, 12 Oct 2023 - 0h
-
18 - Day One Highlights of MSMilan2023Wed, 11 Oct 2023 - 0h
-
17 - Behind the landmark WHO decision on essential medicines for MSThu, 21 Sep 2023 - 0h
-
16 - Women with MSThu, 10 Aug 2023 - 0h
-
15 - Utilising Global Data Registries for MS ResearchThu, 29 Jun 2023 - 0h
-
14 - Epstein-Barr Virus and Multiple SclerosisWed, 24 May 2023 - 0h
-
13 - Access For All: Adding MS DMTs to the WHO Essential Medicines ListWed, 12 Apr 2023 - 0h
-
12 - Using Real-World Studies to Compare DMTs in MSWed, 29 Mar 2023 - 0h
-
11 - Remyelination in MS: a New Clinical TrialMon, 06 Mar 2023 - 0h
-
10 - Stem Cell Research in Multiple SclerosisTue, 24 Jan 2023 - 0h
-
9 - ECTRIMS 2022 For People with MS: Part 3Wed, 28 Dec 2022 - 0h
-
8 - ECTRIMS 2022 For People with MS: Part 2Wed, 21 Dec 2022 - 0h
-
7 - ECTRIMS 2022 For People with MS: Part 1Sat, 17 Dec 2022 - 0h
-
6 - Rethinking how different types of MS are describedSat, 19 Nov 2022 - 0h
-
5 - The role of the MS nurse & the need for more globally: an ECTRIMS 2022 recapWed, 16 Nov 2022 - 0h
-
4 - ECTRIMS 2022 Wrap-upSat, 29 Oct 2022 - 0h
-
3 - Day Two Highlights of ECTRIMS 2022Fri, 28 Oct 2022 - 0h
-
2 - Day One Highlights of ECTRIMS 2022Thu, 27 Oct 2022 - 0h
Show more episodes
5
